找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Critical Issues in Head and Neck Oncology; Key Concepts from th Jan B. Vermorken,Volker Budach,Brian O’Sullivan Conference proceedings‘‘‘‘‘

[復(fù)制鏈接]
樓主: burgeon
21#
發(fā)表于 2025-3-25 07:22:51 | 只看該作者
Promising Biomarkers for Early Diagnosis and Prognosis Prediction such as PDL-1 and NTRK are now finding applications in head and neck cancer care. Immunohistochemistry is an attractive option because of its rapid turnaround time and convenience but molecular testing is often necessary for validation. This chapter will focus on some selected biomarkers being deve
22#
發(fā)表于 2025-3-25 09:33:56 | 只看該作者
23#
發(fā)表于 2025-3-25 12:29:25 | 只看該作者
24#
發(fā)表于 2025-3-25 19:39:21 | 只看該作者
25#
發(fā)表于 2025-3-25 22:10:33 | 只看該作者
NK Cells in Immunotherapy: How Important Are They?totoxic mechanisms. Their functions can be very useful for cancer immunotherapy. But to achieve the maximum support from these extraordinary cells it is necessary to know their effector mechanisms and the mechanisms that lead to their suppression. We have briefly summarized some interesting aspect o
26#
發(fā)表于 2025-3-26 01:26:47 | 只看該作者
27#
發(fā)表于 2025-3-26 06:15:22 | 只看該作者
Novel Approaches in Surgical Management: How to Assess Surgical Marginshe recommendations on margins management relies on two pillars: (1) the observation that groups of cancer cells can leave the macroscopic tumor and disseminate throughout adjacent tissues with different degrees of aggressiveness; (2) the belief that removal of all (or most of) cancer cells can cure
28#
發(fā)表于 2025-3-26 09:26:30 | 只看該作者
29#
發(fā)表于 2025-3-26 13:32:34 | 只看該作者
30#
發(fā)表于 2025-3-26 17:44:50 | 只看該作者
High-Dose Three-Weekly or Low-Dose Weekly Cisplatin during Radiation, What to Prefer?ve or adjuvant radiotherapy can significantly improve locoregional control and survival. One of the major drawbacks is severe acute toxicity with about 40% of patients developing mucositis, up to one fourth suffering from dysphagia, and at least 20% having bone marrow suppression. Late toxicity has
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 13:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
千阳县| 诸暨市| 昌黎县| 东乌珠穆沁旗| 中方县| 清新县| 定远县| 华安县| 肇源县| 延庆县| 吴旗县| 枝江市| 于田县| 澄江县| 定襄县| 兴文县| 临城县| 平昌县| 军事| 资阳市| 渭源县| 厦门市| 开远市| 科技| 司法| 黑水县| 共和县| 梅河口市| 平昌县| 米林县| 玉树县| 凤阳县| 平乡县| 安康市| 富蕴县| 崇明县| 明溪县| 玉山县| 旬邑县| 满城县| 榆中县|